FREDERICK, Md., July 15, 2021 /PRNewswire-PRWeb/ — Beckham Gumbin Ventures (BGV), a commercial real estate investor and developer, is beginning construction on brand new R&D laboratory spec suites and amenities at Ballenger Bio (321 Ballenger Center Drive) in Frederick, Maryland. Ballenger Bio will offer several 3,000 to 7,000 SF R&D laboratory spec suites, with the ability to combine up to 37,000 SF of contiguous space on a single floor. Building such spec labs will allow for growing biotech companies to focus on their business as opposed to construction costs and timelines.
{iframe}https://www.benzinga.com/pressreleases/21/07/n22002435/beckham-gumbin-ventures-announces-ballenger-bio-a-life-sciences-conversion-and-innovation-center-c{/iframe}